Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

New compounds may soon be tested to treat excessive hair growth in women.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Personalized treatment plans are important for people with alopecia areata.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.